VRValeria Magali Rocha-Rocha

Valeria Magali Rocha-Rocha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valeria Magali Rocha-Rocha has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital Health Communication and Vaccine Confidence in Mexico Using Aggregated Randomized Brand Lift Studies: Secondary Analysis

    by Berenice Muñoz Cordero, Rodrigo Romero Feregrino, Raúl Romero Cabello, Valeria Magali Rocha Rocha, Roberto Martinez-Medina, Liliana Aline Fernández Urrutia

    Background: Digital vaccination campaigns are increasingly used to address declining vaccine confidence, yet evidence from large-scale, real-world interventions in middle-income countries is limited. Meta’s Brand Lift Studies (BLS), which use randomized test-control exposure, provide Bayesian estimates of attitudinal shifts resulting from digital content. Mexico, with over 88.6 million active internet users, provides a setting to evaluate the impact of targeted campaigns on vaccine attitudes. Objective: This study evaluated the impact of 5 digital vaccination campaigns implemented by the Asociación Mexicana de Vacunología (@Vacunologia) on Facebook (Meta Platforms Inc) and Instagram (Meta Platforms Inc) in Mexico between 2021 and 2022 on key attitudinal constructs related to COVID-19 vaccine confidence. Methods: This study used a retrospective ecological design. We analyzed aggregated BLS results for 5 campaigns targeting different audiences and vaccination themes. Measured outcomes included standard ad recall, perceived importance, perceived safety, perceived efficacy, and concerns about side effects. Statistical significance within the BLS framework was defined as an incremental lift of ≥2 percentage points with ≥90% posterior probability of replication—a threshold consistent with Meta’s operational Bayesian approach. Exploratory comparisons across campaigns were conducted using 1-way ANOVA, unpaired 2-tailed t tests, and Fisher exact tests. Results: Campaigns reached 84.9 million accounts and generated 179.4 million impressions with a total investment of US $215,600. All campaigns produced statistically significant improvements in at least one attitudinal outcome (Bayesian threshold ≥90%). Standard ad recall increased in 4 campaigns (ANOVA, P <.001), and concerns about side effects decreased in 2 campaigns ( t test, P =.049; P =.006). Perceived safety, importance, and efficacy improved in selected audiences, with stronger effects observed among younger users and women (ANOVA, P =.005). No direct behavioral outcomes (eg, vaccination uptake) were measured; therefore, the findings reflect attitudinal rather than behavioral change. However, these constructs are recognized as proximal predictors of vaccine decision-making and constitute health-related outcomes. Conclusions: Large-scale digital vaccination campaigns can meaningfully strengthen attitudinal determinants of vaccine confidence in a middle-income context. These social media advertising campaigns effectively increased standard ad recall and improved perceptions of vaccine importance and safety, particularly among younger audiences and women in urban areas. However, changes in efficacy perceptions and concerns about side effects were limited. The innovation and implications of this study lie in evaluating large-scale, real-world digital vaccine campaigns in Latin America using experimental BLS data. Findings highlight that audience segmentation yields stronger perceptual shifts, suggesting that tailored digital strategies can complement traditional public health communication. While the BLS does not measure behavioral end points, the observed attitudinal improvements represent foundational steps toward influencing vaccine-related behaviors. Future work should link digital attitudinal metrics with vaccination and epidemiological data to assess real-world health impact.

  • Open Access

    Nineteen-Year Evidence on Measles–Mumps–Rubella Immunization in Mexico: Programmatic Lessons and Policy Implications

    by Rodrigo Romero-Feregrino, Raul Romero-Feregrino, Raul Romero-Cabello, Berenice Muñoz-Cordero, Benjamin Madrigal-Alonso, Valeria Magali Rocha-Rocha

    Background: In Mexico, the measles vaccine was first introduced in 1971. The last case of measles acquired through endemic transmission was recorded in 1995. In 1998, the monovalent measles vaccine was replaced by the combined measles–mumps–rubella (MMR) vaccine. The MMR vaccination schedule consists of two doses: the first is administered at 12 months of age, and the second is administered at either 18 months or 6 years of age. Materials and Methods: A retrospective analysis was conducted using secondary data from 2006 to 2024. Vaccine procurement and administration records from IMSS, ISSSTE, and SSA were reviewed to evaluate the performance of both the MMR and MR programs, focusing particularly on the trends in coverage and data consistency across institutions. Results: The analysis revealed persistent inconsistencies between vaccine procurement and administration for both the MMR and MR vaccines across all institutions. Several years exhibited notable mismatches, including surpluses and deficits in the administered doses relative to their procurement. Between 2006 and 2024, only 69 million of the 91.6 million required MMR doses were administered in Mexico, leaving a deficit of approximately 22.5 million doses (25% of the target population). For MR, a cumulative deficit of approximately 24.6 million procured but unadministered doses was identified. National coverage remained suboptimal, with significant variability across years and institutions. Comparisons with WHO and ENSANUT data indicated marked discrepancies. The seroprevalence findings, along with the 2025 measles outbreak, confirm significant gaps in immunity. Discussion: This study highlights systemic challenges in Mexico’s MMR vaccination program, including inconsistencies in vaccine procurement, administration, and reported coverage across institutions. Overestimated official MMR coverage rates and unclear target definitions for MR contribute to program inefficiencies and missed vaccination opportunities. The resurgence of measles in 2025, along with persistently high incidences of mumps, aligns with the observed immunity gaps, although a direct causal relationship cannot be established from this study. These findings are consistent with previous national studies and seroprevalence data. Conclusions: Despite limitations in the data, this study effectively evaluated the performance of Mexico’s MMR vaccination program, identifying critical gaps in coverage, data reliability, and operational alignment. The findings underscore the need for improved procurement planning, harmonized coverage estimates, and robust monitoring systems. To address the existing gaps in immunity, catch-up campaigns should prioritize the use of the MMR vaccine over MR. Strengthening nominal coverage tracking and implementing evidence-based strategies are essential to restoring public trust and maintaining the goals of measles elimination.


  • Open Access

    Histomorphometric Evaluation of New Bone Formation, Dimensional Changes, and Residual Particles in Alveolar Ridge Preservation Techniques Using InterOss® Anorganic Cancellous Bone Graft: A Longitudinal Study

    by Melanie Karoly Elizalde-Mota, Cindy Hernández-Romero, Sergio Sanchez-Sosa, Valeria Magali Rocha–Rocha, Maritza Espinosa-Arreola

    Background and Objective. Following tooth extraction, socket healing leads to bone remodeling, which generally results in significant local anatomical changes in the height and width of the residual alveolar ridge. This study aimed to compare dimensional changes through histological and histomorphometric evaluation of newly formed bone and residual graft particles. Materials and Methods. We worked on 14 single‐root or premolar teeth with fused roots with an indication for the preservation of the alveolar ridge and the subsequent placement of a dental implant. The techniques performed in the study were the Bartee technique for the preservation of the alveolar crest in seven teeth that presented a good amount of the remaining bone tissue (minimum 4 mm in the apical–coronal direction) or that had a buccal or lingual/palatine wall defect (group A) and the Bio‐Col alveolar preservation technique (group B), in seven teeth that presented an intact alveolus (four remaining walls). Xenograft was used in both groups. Results: Morphometric evaluation of group A (Bartee technique) and group B (Bio‐Col technique) showed 11.48% and 13.24% of reabsorption in the vertical direction (p = 0.482) and 21.95% and 20.55% in the horizontal direction, respectively (p = 0.949). At 6 months of healing, the histomorphometric evaluation showed 31.10% new bone formation and 28.09% residual particles in group A, 13.24% new bone formation (p = 0.744), and 20.55% residual particles for group B (p = 0.302). There were no statistically significant differences in dimensional changes between both groups. Conclusions. The Bartee and Bio‐Col alveolar ridge preservation technique combined with a xenograft provides dimensional stability, counteracting the physiological resorption process and ensuring the stability of the surrounding tissues. Therefore, both techniques represent a predictable option for dental implant placement at 6 months of healing.


  • Open Access

    Report of the Influenza Vaccination Program in Mexico (2006–2022) and Proposals for Its Improvement

    by Rodrigo Romero-Feregrino, Raúl Romero-Cabello, Mario Alfredo Rodríguez-León, Valeria Magali Rocha-Rocha, Raúl Romero-Feregrino, Berenice Muñoz-Cordero

    Background: Influenza has continued to be an important public health challenge, and the WHO recommends that countries consider vaccination for persons at high risk. Mexico has such a program, and we sought to determine its current situation. Material and Methods: This study has an ecological, longitudinal, and retrospective design based on secondary information on the acquisition and application of vaccines against influenza from official data from 2006 to 2022. Results: We found annual variability in the numbers of purchases and application of doses, with coverage of less than 90% of the total population every year; in addition, 17 million vaccines were not used in this period. Discussion: This study shows the situation of the program at the national level. Two institutions acquired fewer the vaccines, while one purchased more for its target population, but the necessary vaccinations were not acquired. On average, 1.7 million of the vaccines purchased annually were not used, but in some years, more vaccines were applied than were purchased in all of the institutions. We also observed that, between institutions, the vaccine coverage was very different, from 21% to 180%. On average, 6.2 million people were not vaccinated annually, between 16% and 22% of the target population, demonstrating low coverage. When we compared the coverage data that we calculated to the data published by the institutions, a great difference was observed. Conclusions: We found inconsistencies in the data, indicating their unreliability and potential disorganization within the program, as the target populations of each institution were not clear. In addition, the application data may have had reporting errors. Adequate coverage was not achieved, and the coverage was different from that reported in the official sources. We propose the implementation of different systems for control, evaluation, and access to the information of the program.


  • Stress, anxiety, depression and long COVID symptoms

    by Elizabeth Bautista-Rodriguez, Nadia Yanet Cortés-Álvarez, César Rubén Vuelvas-Olmos, Verónica Reyes-Meza, Thelma González-López, César Flores-Delosángeles, Nancy Bibiana Pérez-Silva, Héctor Alberto Aguirre-Alarcón, Jose Luis Cortez-Sanchez, Valeria Magali Rocha-Rocha, et al.

    The development of depression and anxiety symptoms during long COVID may partly result from the biopsychosocial effects of COVID-19 that impact mental health, rather than from the infection alone.T...


  • Open Access

    Effect of the Intake of a Traditional Mexican Beverage Fermented with Lactic Acid Bacteria on Academic Stress in Medical Students

    by Laura Márquez-Morales, Elie G. El-Kassis, Judith Cavazos-Arroyo, Valeria Rocha-Rocha, Fidel Martínez-Gutiérrez, Beatriz Pérez-Armendáriz

    Dysbiosis of the gut microbiota has been associated with different illnesses and emotional disorders such as stress. Traditional fermented foods that are rich in probiotics suggest modulation of dysbiosis, which protects against stress-induced disorders. The academic stress was evaluated in medical students using the SISCO Inventory of Academic Stress before and after ingestion of an aguamiel-based beverage fermented with Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus brevis (n = 27) and a control group (n = 18). In addition, microbial phyla in feces were quantified by qPCR. The results showed that the consumption of 100 mL of a beverage fermented with lactic acid bacteria (3 × 108 cfu/mL) for 8 weeks significantly reduced academic stress (p = 0.001), while the control group (placebo intervention) had no significant changes in the perception of academic stress (p = 0.607). Significant change (p = 0.001) was shown in the scores for environmental demands, and physical and psychological factors. Consumption of the fermented beverage significantly increased the phyla Firmicutes and Bacteroidetes but not Gammaproteobacteria. No significant changes were found in the control group, except for a slight increase in the phylum Firmicutes. The intake of this fermented beverage suggest a modulation of gut microbiota and possible reduction in stress-related symptoms in university students, without changing their lifestyle or diet.